The weekly litigation news digest is live. Subscribe now

Methods Of Analysing Cell Free Polynucleotides - EP3842551

The patent EP3842551 was granted to Guardant Health on Nov 1, 2023. The application was originally filed on Sep 4, 2013 under application number EP21155582A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3842551

GUARDANT HEALTH
Application Number
EP21155582A
Filing Date
Sep 4, 2013
Status
Granted And Under Opposition
Sep 29, 2023
Publication Date
Nov 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MARGARET DIXONAug 1, 2024MEWBURN ELLISADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2001053519
DESCRIPTIONUS2003152490
DESCRIPTIONUS2011160078
DESCRIPTIONUS6582908
DESCRIPTIONUS7537897
OPPOSITIONUS2012020537
OPPOSITIONUS2012071331
OPPOSITIONWO2012042374
OPPOSITIONWO2012142213
OPPOSITIONWO2012148477
OPPOSITIONWO2013123442
OPPOSITIONWO2013142389
SEARCHUS8209130
SEARCHWO2008154317

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents